Expression of c-mos proto-oncogene transcripts in mouse tissues.

Two proto-oncogenes implicated in mammary carcinogenesis, int-1 and int-2, are independently regulated during mouse development. Proc Natl Acad Sci U S A (1986) 3.34

Developmental expression of Sp1 in the mouse. Mol Cell Biol (1991) 2.73

c-mos proto-oncogene RNA transcripts in mouse tissues: structural features, developmental regulation, and localization in specific cell types. Mol Cell Biol (1987) 2.35

Proto-oncogene c-ros codes for a molecule with structural features common to those of growth factor receptors and displays tissue specific and developmentally regulated expression. Mol Cell Biol (1986) 1.88

Translational control by cytoplasmic polyadenylation of c-mos mRNA is necessary for oocyte maturation in the mouse. EMBO J (1994) 1.80

Xenopus homolog of the mos protooncogene transforms mammalian fibroblasts and induces maturation of Xenopus oocytes. Proc Natl Acad Sci U S A (1989) 1.69

Expression of c-mos RNA in germ cells of male and female mice. Proc Natl Acad Sci U S A (1987) 1.68

The 'second-codon rule' and autophosphorylation govern the stability and activity of Mos during the meiotic cell cycle in Xenopus oocytes. EMBO J (1992) 1.63

Microinjection of antisense c-mos oligonucleotides prevents meiosis II in the maturing mouse egg. Proc Natl Acad Sci U S A (1989) 1.48

Distinct developmental patterns of c-mos protooncogene expression in female and male mouse germ cells. Proc Natl Acad Sci U S A (1987) 1.46

A novel mammalian protein kinase gene (mak) is highly expressed in testicular germ cells at and after meiosis. Mol Cell Biol (1990) 1.46

Nucleotide sequence and biochemical activities of the Moloney murine sarcoma virus strain HT-1 mos gene. J Virol (1985) 1.44

Nucleotide sequence of testis-derived c-abl cDNAs: implications for testis-specific transcription and abl oncogene activation. Proc Natl Acad Sci U S A (1987) 1.31

Mouse Mos protooncogene product is present and functions during oogenesis. Proc Natl Acad Sci U S A (1989) 1.30

Viral transfer, transcription, and rescue of a selectable myeloproliferative sarcoma virus in embryonal cell lines: expression of the mos oncogene. Mol Cell Biol (1986) 1.29

Chicken homolog of the mos proto-oncogene. Mol Cell Biol (1988) 1.21

The casein kinase II beta subunit binds to Mos and inhibits Mos activity. Mol Cell Biol (1997) 1.16

Expression of cellular protooncogenes in the mouse male germ line: a distinctive 2.4-kilobase pim-1 transcript is expressed in haploid postmeiotic cells. Proc Natl Acad Sci U S A (1988) 1.07

Evidence for the involvement of the proto-oncogene c-mos in mammalian meiotic maturation and possibly very early embryogenesis. EMBO J (1988) 0.99

Differential regulation of Raf-1 and B-Raf and Ras-dependent activation of mitogen-activated protein kinase by cyclic AMP in PC12 cells. Mol Cell Biol (1995) 0.98

c-mos expression in mouse oocytes is controlled by initiator-related sequences immediately downstream of the transcription initiation site. Mol Cell Biol (1991) 0.98

Differential occurrence of CSF-like activity and transforming activity of Mos during the cell cycle in fibroblasts. EMBO J (1992) 0.97

Ontogeny of sex differences in the mammalian hypothalamus and preoptic area. Cell Mol Neurobiol (1997) 0.97

Mos activates myogenic differentiation by promoting heterodimerization of MyoD and E12 proteins. Mol Cell Biol (1997) 0.89

Nucleoside triphosphate-dependent DNA-binding properties of mos protein. Proc Natl Acad Sci U S A (1987) 0.85

A temperature-sensitive mutant of the myeloproliferative sarcoma virus, altered by a point mutation in the mos oncogene, has been modified as a selectable retroviral vector. J Virol (1987) 0.85

Identification of a candidate c-mos repressor that restricts transcription of germ cell-specific genes. Mol Cell Biol (1995) 0.84

Identification of a negative regulatory element that inhibits c-mos transcription in somatic cells. Mol Cell Biol (1992) 0.81

Neuropathological changes in transgenic mice carrying copies of a transcriptionally activated Mos protooncogene. Proc Natl Acad Sci U S A (1990) 0.80

Identification of a cis acting element responsible for muscle specific expression of the c-mos protooncogene. Nucleic Acids Res (1993) 0.80

In silico identification and molecular characterization of genes predominantly expressed in the fish oocyte. BMC Genomics (2008) 0.79

The repressor sequence upstream of c-mos acts neither as polyadenylation site nor as transcription termination region. Nucleic Acids Res (1986) 0.78

Expression of the v-mos gene alters a Mr 55,000 protein during acute infection by Moloney murine sarcoma virus. Proc Natl Acad Sci U S A (1986) 0.78

Changes in c-onc expression during embryonal carcinoma cell differentiation. Environ Health Perspect (1989) 0.76

In vitro growth rate of placental fibroblasts is developmentally regulated. J Clin Invest (1991) 0.75

The molecular biology of chromosome alterations in myelogenous leukemia. West J Med (1985) 0.75

Increased amount of a 25-kilodalton phosphoprotein after v-mos transfection of CHO cells. Mol Cell Biol (1988) 0.75

Identification of protein tyrosine phosphatase 1B and casein as substrates for 124-v-Mos. BMC Biochem (2002) 0.75

Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science (1998) 10.53

Transformation of mammalian cells by constitutively active MAP kinase kinase. Science (1994) 8.69

Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science (1991) 8.68

Nucleotide sequences of integrated Moloney sarcoma provirus long terminal repeats and their host and viral junctions. Proc Natl Acad Sci U S A (1980) 7.77

Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature (1984) 5.85

Properties of a normal mouse cell DNA sequence (sarc) homologous to the src sequence of Moloney sarcoma virus. Science (1980) 5.30

Construction and characterization of a recombinant plasmid encoding the gene for the thymidine kinase of Herpes simplex type 1 virus. Gene (1979) 5.09

Abnormal centrosome amplification in the absence of p53. Science (1996) 4.60

Function of c-mos proto-oncogene product in meiotic maturation in Xenopus oocytes. Nature (1988) 4.24

Mechanism of met oncogene activation. Cell (1986) 4.20

The c-mos proto-oncogene product is a cytostatic factor responsible for meiotic arrest in vertebrate eggs. Nature (1989) 4.13

Construction of a general human chromosome jumping library, with application to cystic fibrosis. Science (1987) 3.87

Inactivation of LRG-47 and IRG-47 reveals a family of interferon gamma-inducible genes with essential, pathogen-specific roles in resistance to infection. J Exp Med (2001) 3.64

Cloning of herpes simplex type 1 DNA fragments in a bacteriophage lambda vector. Science (1979) 3.47

The human met oncogene is related to the tyrosine kinase oncogenes. Nature (1985) 3.46

Biological activity of cloned Moloney sarcoma virus DNA: Terminally redundant sequences may enhance transformation efficiency. Proc Natl Acad Sci U S A (1980) 3.29

Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner. Proc Natl Acad Sci U S A (1997) 3.19

Structures of two spliced herpes simplex virus type 1 immediate-early mRNA's which map at the junctions of the unique and reiterated regions of the virus DNA S component. J Virol (1981) 3.19

Human DNA sequence homologous to the transforming gene (mos) of Moloney murine sarcoma virus. Proc Natl Acad Sci U S A (1982) 3.14

Genomic instability and apoptosis are frequent in p53 deficient young mice. Oncogene (1997) 3.01

Cloning of integrated Moloney sarcoma proviral DNA sequences in bacteriophage lambda. Proc Natl Acad Sci U S A (1979) 2.98

Activating mutations for the met tyrosine kinase receptor in human cancer. Proc Natl Acad Sci U S A (1997) 2.92

Mos stimulates MAP kinase in Xenopus oocytes and activates a MAP kinase kinase in vitro. Mol Cell Biol (1993) 2.87

Pathogen-specific loss of host resistance in mice lacking the IFN-gamma-inducible gene IGTP. Proc Natl Acad Sci U S A (2000) 2.80

The product of the mos proto-oncogene as a candidate "initiator" for oocyte maturation. Science (1989) 2.58

Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor. Mol Cell Biol (1992) 2.53

Met receptor tyrosine kinase: enhanced signaling through adapter proteins. Oncogene (2000) 2.52

DNA sequence of an immediate-early gene (IEmRNA-5) of herpes simplex virus type I. Nucleic Acids Res (1982) 2.50

Specific proteolysis of the c-mos proto-oncogene product by calpain on fertilization of Xenopus eggs. Nature (1989) 2.47

Structure of varicella-zoster virus DNA. J Virol (1981) 2.43

Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway. Mol Cell Biol (1997) 2.43

Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation. Proc Natl Acad Sci U S A (1994) 2.36

c-mos proto-oncogene RNA transcripts in mouse tissues: structural features, developmental regulation, and localization in specific cell types. Mol Cell Biol (1987) 2.35

A novel germ line juxtamembrane Met mutation in human gastric cancer. Oncogene (2000) 2.35

Targeted inactivation of plectin reveals essential function in maintaining the integrity of skin, muscle, and heart cytoarchitecture. Genes Dev (1997) 2.32

Met and hepatocyte growth factor/scatter factor expression in human gliomas. Cancer Res (1997) 2.30

The met proto-oncogene receptor and lumen formation. Science (1992) 2.08

Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network. Mol Cell Biol (1996) 2.05

Meiotic initiation by the mos protein in Xenopus. Nature (1992) 2.00

New method for detecting cellular transforming genes. Science (1982) 1.92

Hepatocyte growth factor/scatter factor-Met signaling in tumorigenicity and invasion/metastasis. J Mol Med (Berl) (1996) 1.91

Sodium dodecylsulfate-dependent anomalies in gel electrophoresis: alterations in the banding patterns of foot-and-mouth disease virus polypeptides. Anal Biochem (1974) 1.81

The Met proto-oncogene mesenchymal to epithelial cell conversion. Science (1994) 1.77

The mutationally activated Met receptor mediates motility and metastasis. Proc Natl Acad Sci U S A (1998) 1.76

The inducibly expressed GTPase localizes to the endoplasmic reticulum, independently of GTP binding. J Biol Chem (1997) 1.75

Culture and characteristics of hormone-responsive neuroblastoma X glioma hybrid cells. Methods Enzymol (1985) 1.70

Identification of a novel GTPase, the inducibly expressed GTPase, that accumulates in response to interferon gamma. J Biol Chem (1996) 1.66

Characterization of the TPR-MET oncogene p65 and the MET protooncogene p140 protein-tyrosine kinases. Proc Natl Acad Sci U S A (1988) 1.64

Three additional DNA polymorphisms in the met gene and D7S8 locus: use in prenatal diagnosis of cystic fibrosis. J Pediatr (1987) 1.63

Signaling pathways in Ras-mediated tumorigenicity and metastasis. Proc Natl Acad Sci U S A (1998) 1.63

Evidence that MIG-6 is a tumor-suppressor gene. Oncogene (2006) 1.62

The von Hippel-Lindau tumor suppressor gene inhibits hepatocyte growth factor/scatter factor-induced invasion and branching morphogenesis in renal carcinoma cells. Mol Cell Biol (1999) 1.62

Structure, tissue-specific expression, and transforming activity of the mouse met protooncogene. Cell Growth Differ (1990) 1.62

The ras oncogene-mediated sensitization of human cells to topoisomerase II inhibitor-induced apoptosis. J Natl Cancer Inst (1999) 1.61

Molecular cloning and physical mapping of varicella-zoster virus DNA. Proc Natl Acad Sci U S A (1982) 1.60

Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models. Proc Natl Acad Sci U S A (2001) 1.58

An activated rasN gene: detected in late but not early passage human PA1 teratocarcinoma cells. Science (1984) 1.56

Cells transformed by certain strains of Moloney sarcoma virus contain murine p60. Cell (1977) 1.56

Determination of v-Mos-catalyzed phosphorylation sites and autophosphorylation sites on MAP kinase kinase by ESI/MS. Biochemistry (1995) 1.52

Down-regulation of MET, the receptor for hepatocyte growth factor. Oncogene (2001) 1.52

Met expression and sarcoma tumorigenicity. Cancer Res (1993) 1.50

Novel features of the light chain of microtubule-associated protein MAP1B: microtubule stabilization, self interaction, actin filament binding, and regulation by the heavy chain. J Cell Biol (1998) 1.47

MAP1B is required for axon guidance and Is involved in the development of the central and peripheral nervous system. J Cell Biol (2000) 1.44

Physical map of the origin of defective DNA in herpes simplex virus type 1 DNA. J Virol (1978) 1.44

Nucleotide sequence and biochemical activities of the Moloney murine sarcoma virus strain HT-1 mos gene. J Virol (1985) 1.44

Positive feedback between MAP kinase and Mos during Xenopus oocyte maturation. Dev Biol (1996) 1.39

Persistent herpes simplex virus infections established in two Burkitt lymphoma derived cell lines. J Gen Virol (1976) 1.38

A p60 polypeptide in the feline leukemia virus pseudotype of Moloney sarcoma virus with murine leukemia virus p30 antigenic determinants. Proc Natl Acad Sci U S A (1975) 1.37

Long terminal repeat enhancement of v-mos transforming activity: identification of essential regions. J Virol (1983) 1.36

Ability of the c-mos product to associate with and phosphorylate tubulin. Science (1991) 1.35

Analysis of the early embryonic cell cycles of Xenopus; regulation of cell cycle length by Xe-wee1 and Mos. Development (1998) 1.33

Mouse Mos protooncogene product is present and functions during oogenesis. Proc Natl Acad Sci U S A (1989) 1.30

Autocrine hepatocyte growth factor/scatter factor-Met signaling induces transformation and the invasive/metastastic phenotype in C127 cells. Oncogene (1996) 1.30

Isolation of the structural polypeptides of foot-and-mouth disease virus and analysis of their C-terminal sequences. Virology (1973) 1.30

Mouse c-mos oncogene activation is prevented by upstream sequences. Proc Natl Acad Sci U S A (1984) 1.30

Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways. Proc Natl Acad Sci U S A (2001) 1.28

Synergy between the Mos/mitogen-activated protein kinase pathway and loss of p53 function in transformation and chromosome instability. Mol Cell Biol (1997) 1.28

Tumorigenesis induced by coexpression of human hepatocyte growth factor and the human met protooncogene leads to high levels of expression of the ligand and receptor. Cell Growth Differ (1993) 1.27

The Mos/mitogen-activated protein kinase (MAPK) pathway regulates the size and degradation of the first polar body in maturing mouse oocytes. Proc Natl Acad Sci U S A (1996) 1.25

Characterization of integrated Moloney Sarcoma proviruses and flanking host sequences cloned in bacteriophage lambda. Cold Spring Harb Symp Quant Biol (1980) 1.24

The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-met-urokinase plasminogen activator-plasmin proteolytic network. Cancer Res (2000) 1.23

Expression and functional interaction of hepatocyte growth factor-scatter factor and its receptor c-met in mammalian brain. J Cell Biol (1994) 1.21

Chicken homolog of the mos proto-oncogene. Mol Cell Biol (1988) 1.21

Enhanced sensitivity to 1-beta-D-arabinofuranosylcytosine and topoisomerase II inhibitors in tumor cell lines harboring activated ras oncogenes. Cancer Res (1996) 1.21

A characterization of cytostatic factor activity from Xenopus eggs and c-mos-transformed cells. J Cell Biol (1991) 1.21

Anthrax toxins. Cell Mol Life Sci (1999) 1.20

Characterization of human transforming genes from chemically transformed, teratocarcinoma, and pancreatic carcinoma cell lines. Cancer Res (1984) 1.17

Normal and malignant prostate epithelial cells differ in their response to hepatocyte growth factor/scatter factor. Am J Pathol (2001) 1.17

Evidence for non-covalent clusters of the c-met proto-oncogene product. Oncogene (1992) 1.16

Characterization of the rearranged tpr-met oncogene breakpoint. Mol Cell Biol (1987) 1.15

Sequences upstream from the mouse c-mos oncogene may function as a transcription termination signal. DNA (1986) 1.14

The ins and outs of p53. Nat Cell Biol (2000) 1.14

Inhibition of mos-induced oocyte maturation by protein kinase A. J Cell Biol (1993) 1.13

Met proto-oncogene product is overexpressed in tumors of p53-deficient mice and tumors of Li-Fraumeni patients. Cancer Res (1995) 1.10

Signal transduction in c-met mediated motogenesis. EXS (1993) 1.10

Suppression of Ras-mediated tumorigenicity and metastasis through inhibition of the Met receptor tyrosine kinase. Proc Natl Acad Sci U S A (2001) 1.10

Proto-oncogene expression in germ cell development. Trends Genet (1988) 1.09